NEWTON, MA, USA I February 04, 2025 I Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory disease, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback